Track 1 (Theatre 1)
| Symposium 1: Epidemiology related to AMR | ||
| Moderator: Prof. Po Ren Hseuh | ||
| 11:30-11:55 | Impact of difficult-to-treat resistance in gram-negative bacteremia on mortality | Prof. Kyungmin Huh (Korea) |
| 11:55-12:20 | Antimicrobial resistance of clinical bacterial isolates in China: current status and trends | Prof. Minggul Wang (China) |
| 12:20-12:45 | Carbapenem-resistant acinetobacter baumannii | Prof. Visanu Thamlikitkul (Thailand) |
| 12:45-13:00 | Discussion | |
| 13:00-14:00 | Lunch | |
| Keynote Session 1: Strategies to overcome antimicrobial resistance | ||
| Moderator: Dr. Jacky Chan, Dr. May Lee | ||
| 14:00-14:25 | Keynote 1: Evolution of resistance: expect the unexpected | Prof. David Livermore (UK) |
| 14:25-14:50 | Keynote 2: Antimicrobial resistance: how should we tackle? | Prof. Kwok-Yung Yuen (Hong Kong, China) |
| 15:15-15:40 | Keynote 3: Rapid microbiologic tests and their clinical implications | Prof. Robin Patel (USA) |
| 15:40-16:00 | Coffee Break | |
| Keynote Session 2: Preparing for the next pandemic | ||
| Moderator: Dr. Chris Lai, Dr. Wilson Lam | ||
| 16:25-16:50 | Keynote 4: WHO antimicrobial resistance | Dr Takeshi Nishijima (Japan) |
| 16:50-17:15 | Keynote 5: Treatment of MDR gram-negative infections | Prof. David Paterson (Singapore) |
| 17:15-17:40 | Keynote 6: Combating infectious diseases and AMR with AI : Opportunities and Challenges | Prof. Jae-Hoon Song (South Korea) |
| 17:40-18:10 | Opening Ceremony | |
Track 2 (Theatre 2)
| Symposium 2: Cutting edge diagnostics to combat AMR | ||
| Moderator: Prof. Charles Chiu | ||
| 11:30-11:55 | Diagnostic tools for biofilm-associated infections - Focus on PJI | Prof. Robin Patel (USA) |
| 11:55-12:20 | One health surveillance reveals the hidden AMR highway in Hong Kong | Prof. Gilman Siu (Hong Kong, China) |
| 12:20-12:45 | Genomic surveillance for enhanced control of antimicrobial resistance | Prof. Margaret Ip (Hong Kong, China) |
| 12:45-13:00 | Discussion | |
Track 3 (Convention Hall C)
| Symposium 3: One Health | ||
| Moderator: Dr. Ada Lin | ||
| 11:30-11:55 | Combating Antimicrobial Resistance in the Post-pandemic Era: Hong Kong’s experience | Dr Edmond Ma (Hong Kong, China) |
| 11:55-12:20 | Antimicrobial allergy labelling and delabelling | Dr Philip Li (Hong Kong, China) |
| 12:20-12:45 | Environmental surveillance of AMR | Prof. Tong Zhang (Hong Kong, China) |
| 12:45-13:00 | Discussion | |
Track 1 (Theatre 1)
| Moderator: Dr Chris Lai | ||
| 09:10-09:50 | Plenary 1: A New Era in MDR/RR-TB Treatment: Shorter All-Oral Regimens | Prof. Jae-Joon Yim (Korea) |
| 09:50-10:30 | Plenary 2: Metagenomic sequencing and AI driven diagnostics | Dr Charles Chiu (USA) |
| 10:30-11:00 | Coffee Break | |
| Symposium 4: Fungus: Anti-fungal Resistance; current trends and strategies to overcome | ||
| Moderator: Prof. Jasper Chan | ||
| 11:00-11:25 | Candidozyma auris (Candida auris): prevalence and antifungal resistance | Prof. Yunfeng WANG (USA) |
| 11:50-12:15 | Antifungal Prophylaxis | Prof. Kelvin To (Hong Kong, China) |
| 12:15-12:30 | Discussion | |
| 12:45-13:45 | Sponsored Lunch Symposium (Convention Hall A&B) | |
| Optimizing HIV Care: Comparing 2 Drug Regimens (2DR) and 3 Drug Regimens (3DR) – Efficacy, Adherence, and Resistance – Sponsored by GSK | Prof. Pedro Cahn (Argentina) | |
| Oral Presentation I - Viral and Fungal Infections | ||
| Moderator: Dr. Ruby Kwong (Hong Kong, China) | ||
| 14:00-14:10 | Regional clustering of influenza A viruses carrying PA I38T in Japan: matched-control HA clustering using GISAID sequences, 2022–2025 | Prof Yusuke Yoshino (Japan) |
| 14:10-14:20 | Targeting Viral Ion Channels: An Efficient Strategy to Develop Antivirals | Dr Hiya LAHIRI (Hong Kong, China) |
| 14:20-14:30 | Generation of Host Genetic Factor Information Known to Associate With Hospitalized Severe Influenza: a Preliminary Analysis | Prof Wai Yin Ng (Hong Kong, China) |
| 14:30-14:40 | MicroRNA-145 Upregulation in High-risk Genotype HPV Infected Atypical Squamous Cells of Undetermined Significance (ASCUS) Liquid Based Cytology Samples | Dr Jason Kam San Wong (Hong Kong, China) |
| Moderator: Prof. Ivan Hung | ||
| 15:00-15:40 | Plenary 3: The challenge in US healthcare and antibiotics resistance | Prof. Tina Tan (USA) |
| 15:40-16:20 | Plenary 4: Diagnostics of MDR micro-organism | Prof. Thierry Naas (France) |
| 16:20-16:40 | Coffee Break | |
| Symposium 7: Vaccine | ||
| Moderator: Dr. Ken Ng, Dr. Jonpaul Zee | ||
| 16:40-17:05 | Impact of vaccine on antimicrobial resistance | Prof. Ivan Hung (Hong Kong, China) |
| 17:05-17:30 | COVID‑19 Vaccination in an Endemic World: Insights from Influenza | Prof. Ben Cowling (Hong Kong, China) |
| 17:30-17:55 | The 2026 Roadmap for HPV-Related Cancer Prevention: Integrating Gender-Neutral Vaccination, Single-Dose Schedules, and Multi-Site Screening Paradigms | Dr. Andrew Wong (Hong Kong, China) |
| 17:55-18:10 | Discussion | |
Track 2 (Theatre 2)
| Symposium 5: HIV- Are we approaching end of pandemic? | ||
| Moderator: Dr. Wilson Lam | ||
| 11:00-11:25 | 1. HIV Drug Resistance Surveillance and its Role in Safe-guiding Ant-retroviral Therapy 2. Current Guidance on Antiretroviral Therapy: Beyond Viral Suppression Toward Patient-Centered HIV Care |
Dr. Yiming Shao (China) |
| 11:25-11:50 | Current guidance in antiviral Rx | Prof Pedro Cahn (Argentina) |
| 11:50-12:15 | HIV drug resistance: treatment strategies | Dr. Graeme Moyle (United Kingdom) |
| 12:15-12:30 | Discussion | |
| 12:45-13:45 | Sponsored Lunch Symposium (Convention Hall A&B) | |
| Optimizing HIV Care: Comparing 2 Drug Regimens (2DR) and 3 Drug Regimens (3DR) – Efficacy, Adherence, and Resistance – Sponsored by GSK | Prof. Pedro Cahn (Argentina) | |
| 14:00-15:00 | Oral Presentation II - Mycobacterial Infection | |
| Moderators: Dr. Daphne Lau (Hong Kong, China), Dr. Thomas Chik (Hong Kong, China) | ||
| 14:00-14:10 | Cost and effectiveness of linezolid for treatment of disseminated non-tuberculous mycobacterial infections in patients with anti-Interferon-gamma autoantibody associated adult-onset immunodeficiency syndrome | Dr Nasikarn Angkasekwinai (Thailand) |
| 14:10-14:20 | Retrospective Analysis of Bactec MGIT 960-based Pyrazinamide Monoresistance Results from a Referral Hospital in Hunan, China | Dr Peilei Hu (China) |
| 14:20-14:30 | Simultaneous Molecular Detection of Mycobacterium Tuberculosis and Multidrug Resistance Using CRISPR-Cas12b-Based Nucleic Acid Assay | Dr Yujiao Hu (China) |
| 14:30-14:40 | Molecular Diagnosis of Multi-drug Resistant Tuberculosis (MDR-TB): Opportunities and Challenges | Dr Wing Cheong YAM (Hong Kong, China) |
| 14:40-14:50 | Directed Evolution Improves Infection Dynamics of Mycobacteroides abscessus Phages | Miss Xinyi Lu (South Korea) |
| 16:20-16:40 | Coffee Break | |
| Symposium 8: Joint session with HKICNA-Infection Control | ||
| Moderator: Dr. Kristine Luk | ||
| 16:40-17:05 | Navigating the changing landscape of infection prevention | Dr. Ling Moi Lin (Singapore) |
| 17:05-17:30 | Convincing Surgeon Colleagues to Listen and Practice IPC | Dr. Anucha Apisarnthanarak (Thailand) |
| 17:30-17:55 | Effectiveness of an AI-Enabled Augmented Reality Hand Hygiene Training Tool in Hong Kong: Findings from a Cluster Randomized Controlled Trial | Prof. Lin Yang (Hong Kong, China) |
| 17:55-18:10 | Discussion | |
Track 3 (Convention Hall C)
Sponsored Lunch Symposium (Convention Hall A&B)
| 12:45-13:45 | Optimizing HIV Care: Comparing 2 Drug Regimens (2DR) and 3 Drug Regimens (3DR) – Efficacy, Adherence, and Resistance – Sponsored by GSK | Prof. Pedro Cahn (Argentina) |
Track 1 (Theatre 1)
| Moderator: Dr. Owen Tsang, Dr. Edmond Ma | ||
| 09:10-09:50 | Plenary 5: Antimicrobial stewardship in hospitals: where are we now in 2026? | Prof. David Lye (Singapore) |
| 09:50-10:30 | Plenary 6: Tackling AMR: A cutting-edge approach to infection prevention and control | Dr. Doo Ryeon Chung (Korea) |
| 10:30-11:00 | Coffee Break | |
| Symposium 10: Recent advance in infectious disease diagnostics | ||
| Moderator: Dr Ken Ng | ||
| 11:00-11:25 | Diagnostic stewardship | Prof. Wing-Hong Seto (Hong Kong, China) |
| 11:25-11:50 | Cervical Cancer Prevention and Beyond: Self-Sampling, NGS and Multiplex Molecular Surveillance | Dr Chris Chan (Hong Kong, China) |
| 11:50-12:15 | Enhancing clinical impact of new parasitic disease detection diagnostics | Dr Samson Wong (Hong Kong, China) |
| 12:15-12:30 | Discussion | |
| 12:45-13:45 | Sponsored Lunch Symposium (Convention Hall C) | |
| 14:00-15:00 | Oral Presentation IV - Antimicrobial Agents | |
| Moderator: Dr. Ruby Kwong (Hong Kong, China) | ||
| 14:00-14:10 | A Three-Phage Combination Effectively Controls a Clinical High-Risk Klebsiella pneumoniae ST307 Isolate Through Complementary Killing and Evolutionary Trapping | Mr Guanwen HUANG (Hong Kong, China) |
| 14:10-14:20 | In Vitro Susceptibility of Delafloxacin and Comparators against Clinical Bacterial Isolates in Taiwan | Dr Sung-Ching Pan (Chinese Taipei) |
| 14:20-14:30 | Targeted inhibition of small RNA00203 disrupts biofilm-mediated antibiotic resistance in Acinetobacter baumannii | Dr Abebe Mekuria Shenkutie (Hong Kong, China) |
| 14:30-14:40 | Mortality Attributable to Mismatch with In Vitro Susceptibility of Empirical Antibiotics in Patients with Bacterial Bloodstream Infections | Mr Guanhao ZHENG (Hong Kong, China) |
| 14:40-14:50 | Genomic and Transcriptomic Analyses Reveal Oxidative Stress Response Pathways as a Determinant of Cefiderocol Activity in Klebsiella pneumoniae | Miss Lana Daoud (United Arab Emirates) |
| 15:00-15:30 | Coffee Break | |
| Symposium 13: Novel treatments | ||
| Moderator: Prof. Margaret Ip | ||
| 15:30-15:55 | Novel antimicrobial in MDRO- where are we now? | Dr. Juan-Pablo Horcajada (Spain) |
| 15:55-16:20 | Immunomodulatory therapy in respiratory viral infections | Prof. David Hui (Hong Kong, China) |
| 16:20-16:45 | From bench to bedside: translating mechanisms of resistance into clinical solutions for Gram-Negative Infections | Dr. Jasmine Chung Shimin (Singapore) |
| 16:45-17:00 | Discussion | |
| 17:00-17:30 | Closing Ceremony | |
Track 2 (Theatre 2)
| Symposium 11: Joint session with GCACMID | ||
| Moderator: Dr Kinveng koon, Mr. Raymond Leung | ||
| 11:00-11:25 | Progress of ChiCAST on breakpoint setup and antimicrobial susceptibility testing standardization | Prof. Qiwen Yang (China) |
| 11:25-11:50 | Tackling refractory NTM-PD: Multidisciplinary approaches and future solutions | Prof. Qing Miao (China) |
| 11:50-12:15 | New advances in laboratory diagnosis of fungal infections | Prof. He Wang (China) |
| 12:15-12:30 | Discussion | |
| 12:45-13:45 | Sponsored Lunch Symposium (Convention Hall C) | |
| 14:00-15:00 | Oral Presentation V - Epidemiology and Surveillance | |
| Moderator: Dr. Alfred Lee (Hong Kong, China) | ||
| 14:00-14:10 | Genomic Epidemiology and Antimicrobial Resistance of Nontyphoidal Salmonella in Retail Meats in Hong Kong: A Comprehensive Surveillance Study Using Whole-Genome Sequencing | Mr Tak Fai Wong (Hong Kong, China) |
| 14:10-14:20 | Integrated One Health Genomic Evidence of Carbapenem-Resistant Escherichia coli Transmission Across Food, Clinical, and Sewage Sources in Hong Kong | Mr Chi Fung Ng (Hong Kong, China) |
| 14:20-14:30 | Mortality burden of antimicrobial resistance in respiratory tract infections in Hong Kong, 2012-2021 | Dr Yun Lin (Hong Kong, China) |
| 14:30-14:40 | Update on Helicobacter pylori Antibiotic Susceptibility in Hong Kong, 2019–2025: Trends, Challenges, and Therapeutic Implications | Dr Sze Tsing Jonpaul Zee (Hong Kong, China) |
| 14:40-14:50 | Antifungal Efficacy of Natural Antiseptic Products Against Candida Auris | Dr Wing Gi Wu (Hong Kong, China) |
| 15:00-15:30 | Coffee Break | |
| Symposium 14: Infection Control | ||
| Moderator: Dr. May Lee | ||
| 15:30-15:55 | Lessons Learnt from Acinetobacter baumannii outbreaks in several settings | Dr. Anucha Apisarnthanarak (Thailand) |
| 15:55-16:20 | MDRO decolonization | Dr. Vincent Cheng (Hong Kong, China) |
| 16:20-16:45 | Candida auris | Dr. David Lung (Hong Kong, China) |
| 16:45-17:00 | Discussion | |
